These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22311042)
1. MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies. Sheng X; Zhang L; Tong N; Luo D; Wang M; Xu M; Zhang Z Mol Biol Rep; 2012 Jul; 39(7):7237-49. PubMed ID: 22311042 [TBL] [Abstract][Full Text] [Related]
2. MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies. Wang J; Wang B; Bi J; Li K; Di J J Cancer Res Clin Oncol; 2012 Jun; 138(6):979-89. PubMed ID: 22358302 [TBL] [Abstract][Full Text] [Related]
3. Association between MDR1 C3435T polymorphism and risk of breast cancer. Wang Z; Wang T; Bian J Gene; 2013 Dec; 532(1):94-9. PubMed ID: 24070710 [TBL] [Abstract][Full Text] [Related]
4. Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies. Chen G; Quan S; Hu Q; Wang L; Xia X; Wu J Mol Biol Rep; 2012 May; 39(5):5161-8. PubMed ID: 22160574 [TBL] [Abstract][Full Text] [Related]
5. Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studies. Qian X; Cao S; Yang G; Dong J; Jin G; Shen Y; Hu Z Leuk Lymphoma; 2012 Jun; 53(6):1183-7. PubMed ID: 22088099 [TBL] [Abstract][Full Text] [Related]
6. MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis. Wang J; Guo X; Yu S; Zhang J; Song J; Ji M; Cao Z; Wang J; Liu Y; Dong W Mol Biol Rep; 2014; 41(4):2679-85. PubMed ID: 24449364 [TBL] [Abstract][Full Text] [Related]
7. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis. Tazzite A; Kassogue Y; Diakité B; Jouhadi H; Dehbi H; Benider A; Nadifi S BMC Genet; 2016 Sep; 17(1):126. PubMed ID: 27580695 [TBL] [Abstract][Full Text] [Related]
8. Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects. Zhao L; Li K; Li W; Yang Z Tumour Biol; 2013 Jun; 34(3):1949-57. PubMed ID: 23504525 [TBL] [Abstract][Full Text] [Related]
9. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Jamroziak K; Balcerczak E; Smolewski P; Robey RW; Cebula B; Panczyk M; Kowalczyk M; Szmigielska-Kapłon A; Mirowski M; Bates SE; Robak T Pharmacol Rep; 2006; 58(5):720-8. PubMed ID: 17085864 [TBL] [Abstract][Full Text] [Related]
10. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan. Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Drug Metab Pharmacokinet; 2013; 28(2):138-43. PubMed ID: 22971641 [TBL] [Abstract][Full Text] [Related]
11. MDR1 C3435T polymorphism in patients with breast cancer. Turgut S; Yaren A; Kursunluoglu R; Turgut G Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460 [TBL] [Abstract][Full Text] [Related]
12. Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Lu PH; Wei MX; Yang J; Liu X; Tao GQ; Shen W; Chen MB Breast Cancer Res Treat; 2011 Jan; 125(2):537-43. PubMed ID: 20625815 [TBL] [Abstract][Full Text] [Related]
13. Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis. Wu DD; Zhang JX; Li J; Dong WG Asian Pac J Cancer Prev; 2014; 15(7):3021-7. PubMed ID: 24815441 [TBL] [Abstract][Full Text] [Related]
14. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children. Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830 [TBL] [Abstract][Full Text] [Related]
15. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma. Mhaidat NM; Alshogran OY; Khabour OF; Alzoubi KH; Matalka II; Haddadin WJ; Mahasneh IO; Aldaher AN J Exp Clin Cancer Res; 2011 Jul; 30(1):68. PubMed ID: 21762523 [TBL] [Abstract][Full Text] [Related]
16. Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. Oliveira J; Felipe AV; Chang PY; Pimenta CA; Silva TD; Massud J; Forones NM Mol Med Rep; 2012 Aug; 6(2):395-8. PubMed ID: 22641402 [TBL] [Abstract][Full Text] [Related]
17. Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey. Turgut S; Turgut G; Atalay EO Mol Biol Rep; 2006 Dec; 33(4):295-300. PubMed ID: 17080296 [TBL] [Abstract][Full Text] [Related]
18. ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies. He T; Mo A; Zhang K; Liu L Colorectal Dis; 2013 Jan; 15(1):12-8. PubMed ID: 23279665 [TBL] [Abstract][Full Text] [Related]
19. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. Siegsmund M; Brinkmann U; Scháffeler E; Weirich G; Schwab M; Eichelbaum M; Fritz P; Burk O; Decker J; Alken P; Rothenpieler U; Kerb R; Hoffmeyer S; Brauch H J Am Soc Nephrol; 2002 Jul; 13(7):1847-54. PubMed ID: 12089380 [TBL] [Abstract][Full Text] [Related]
20. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. Andersen V; Agerstjerne L; Jensen D; Østergaard M; Saebø M; Hamfjord J; Kure E; Vogel U BMC Med Genet; 2009 Feb; 10():18. PubMed ID: 19250544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]